Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma.
- 1 December 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (12) , 1798-1805
- https://doi.org/10.1161/01.atv.13.12.1798
Abstract
The heparin-releasable proteins are a group of proteins that are targeted to the endothelial surface by attachment to glycosaminoglycans and may have functions specific to the endothelium-blood interface. In this study, heparin-affinity chromatography of human postheparin plasma was used as a method to identify and study novel heparin-releasable proteins. Six proteins seen on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels have increased levels in plasma after intravenous heparin. The six proteins are platelet factor 4, midkine, pleiotrophin, and several novel proteins. Midkine and pleiotrophin are related cytokines that are developmentally regulated, neurotrophic, and mitogenic. Additional studies show that levels of midkine and pleiotrophin peak at 10 to 30 minutes after injection of heparin. Heparin-releasable midkine and pleiotrophin do not originate from blood cells or the kidney. Heparin-releasable midkine may originate from endothelial cells. Soft agar culture of an adenocarcinoma cell line (SW-13) demonstrates growth-stimulating activity similar to that described for pleiotrophin in the heparin-agarose eluate of postheparin plasma but not in the heparin-agarose eluate of preheparin plasma. It is concluded there are more heparin-releasable proteins than previously identified, including midkine and pleiotrophin, and that heparin-affinity chromatography of postheparin plasma is a useful technique for identifying novel heparin-releasable proteins.Keywords
This publication has 28 references indexed in Scilit:
- Pleiotrophin gene expression is highly restricted and is regulated by platelet-derived growth factorBiochemical and Biophysical Research Communications, 1992
- Purification of recombinant midkine and examination of its biological activities: Functional comparison of new heparin binding factorsBiochemical and Biophysical Research Communications, 1991
- A new family of heparin-binding factors: Strong conservation of midkine (MK) sequences between the human and the mouseBiochemical and Biophysical Research Communications, 1991
- Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissuesBiochemical and Biophysical Research Communications, 1990
- A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequenceBiochemical and Biophysical Research Communications, 1989
- cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesisBiochemical and Biophysical Research Communications, 1988
- Binding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. Comparisons with lipoprotein lipase binding.Journal of Clinical Investigation, 1985
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Heparin‐induced Diamine Oxidase Increase in Human Blood PlasmaActa Medica Scandinavica, 1966